, Volume 196, Issue 3, pp 343–349 | Cite as

Clinical Determinants of Incremental Shuttle Walk Test in Adults with Bronchiectasis

  • Sulenur Yildiz
  • Deniz Inal-Ince
  • Ebru Calik-Kutukcu
  • Naciye Vardar-Yagli
  • Melda Saglam
  • Hulya Arikan
  • Lutfi Coplu



Exercise capacity is impaired in patients with bronchiectasis. Incremental shuttle walk test (ISWT) stresses cardiorespiratory system physiologically to symptom-limited maximal exercise capacity. The purpose of this study was to investigate the clinical determinants of ISWT in adults with non-cystic fibrosis (CF) bronchiectasis.


Forty-one clinically stable bronchiectasis patients aged 18–72 years (27 females, 14 males) participated in the study. Subjects’ demographics and physical characteristics were recorded. Bronchiectasis Severity Index was used to identify disease severity. Pulmonary function test was performed. Dyspnea perception was assessed using the modified Medical Research Council Dyspnea Scale. Maximum inspiratory and expiratory pressures were measured. Peripheral muscle strength using a hand held dynamometer was measured. ISWT was performed to determine exercise capacity. Fatigue Severity Scale, Hospital Anxiety and Depression Scale, Leicester Cough Questionnaire were used to determine fatigue, psychosocial status, and quality of life.


Patients’ mean ISWT distance was 469.5 m. The ISWT distance was significantly related with age (r = − 0.472), height (r = 0.469), gender (r = 0.520), FEV1 (r = 0.651), and FVC (r = 0.545, p < 0.05). Quadriceps muscle strength was higher in males (p = 0.001) as compared to females. Age and gender were identified as independent predictors of the ISWT, explaining 42% of variance in ISWT distance (r = 0.649, r2 = 0.421, F(2,38) = 13.794, p < 0.001).


The clinical determinants of ISWT in clinically stable patients with non-CF bronchiectasis are age and gender. Pulmonary function, dyspnea perception, muscle strength, disease severity, fatigue, psychosocial factors, and health-related quality of life seems to have an independent effect on ISWT in this group of patients with bronchiectasis.


Non-CF bronchiectasis Exercise capacity Shuttle walk test Pulmonary function Peripheral strength 


Compliance with Ethical Standards

Conflict of interest

None of the authors have any conflict of interest to declare in relation to this work.


  1. 1.
    O’Leary CJ, Wilson CB, Hansell DM et al (2002) Relationship between psychological well-being, and lung health status in patients with bronchiectasis. Respir Med 96:686–692CrossRefPubMedGoogle Scholar
  2. 2.
    Newall C, Stockley RA, Hill SL (2005) Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax 60:943–948CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Koulouris NG, Retsou S, Kosmas E et al (2003) Tidal expiratory flow limitation, dyspnea and exercise capacity in patients with bilateral bronchiectasis. Eur Respir J 21:743–748CrossRefPubMedGoogle Scholar
  4. 4.
    Probst VS, Hernandes NA, Teixeira DC et al (2012) Reference values for the incremental shuttle walking test. Respir Med 106:243–248CrossRefPubMedGoogle Scholar
  5. 5.
    Singh SJ, Morgan MD, Hardman AE et al (1994) Comparison of oxygen uptake during a conventional treadmill test and the shuttle-walking test in chronic airflow limitation. Eur Respir J 17:2016–2020Google Scholar
  6. 6.
    Wilson CB, Jones PW, O’Leary CJ et al (1997) Validation of the St. George’s Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med 156(2 Pt 1):536–541CrossRefPubMedGoogle Scholar
  7. 7.
    de Camargo AA, Amaral TS, Rached SZ et al (2014) Incremental shuttle walking test: a reproducible and valid test to evaluate exercise tolerance in adults with non-cystic fibrosis bronchiectasis. Arch Phys Med Rehabil 95:892–899CrossRefPubMedGoogle Scholar
  8. 8.
    Lee AL, Button BM, Ellis S et al (2009) Clinical determinants of the 6-minute walk test in bronchiectasis. Respir Med 103:780–785CrossRefPubMedGoogle Scholar
  9. 9.
    Chalmers JD, Goeminne P, Aliberti S et al (2014) The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med 189:576–585CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Laszlo G (2006) Standardization of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax 61:744–746CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    American Thoracic Society/European Respiratory Society (2002) ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 166:518–624CrossRefGoogle Scholar
  12. 12.
    Black LF, Hyatt RE (1969) Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Med 99:696–702Google Scholar
  13. 13.
    Bestall JC, Paul EA, Garrod R et al (1999) Usefulness of the medical research council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581–586CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Bohannon RW (1997) Reference values for extremity muscle strength obtained by hand-held dynamometry from adults aged 20 to 79 years. Arch Phys Med Rehabil 78:26–32CrossRefPubMedGoogle Scholar
  15. 15.
    Gosselink R, Troosters T, Decramer M (1996) Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153:976–980CrossRefPubMedGoogle Scholar
  16. 16.
    Aydemir O, Guvenir T, Kuey L et al (1997) Hastane Anksiyete ve Depresyon Ölçeği Türkçe formunun geçerlilik ve güvenilirliği. Türk Psikiyatri Dergisi 8:280–287Google Scholar
  17. 17.
    Armutlu K, Korkmaz NC, Keser I et al (2007) The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res 30:81–85CrossRefPubMedGoogle Scholar
  18. 18.
    Birring SS, Prudon B, Carr AJ et al (2003) Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 58:339–343CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Green SB, Salkind NJ (2008) Using SPSS for Windows and Macintosh: analyzing and understanding data, 5th edn. Prentice Hall, Uppersaddle River, NJGoogle Scholar
  20. 20.
    Gonçalves CG, Mesquita R, Hayashi D et al (2015) Does the Incremental Shuttle Walking Test require maximal effort in healthy subjects of different ages? Physiotherapy 101:141–146CrossRefPubMedGoogle Scholar
  21. 21.
    Woo JS, Derleth C, Stratton JR et al (2006) The influence of age, gender, and training on exercise efficiency. J Am Coll Cardiol 47:1049–1057CrossRefPubMedGoogle Scholar
  22. 22.
    Callisaya ML, Blizzard L, Schmidt MD et al (2008) Sex modifies the relationship between age and gait: a population-based study of older adults. J Gerontol A 63:165–170CrossRefGoogle Scholar
  23. 23.
    Vendrell M, Garcia J, Olveira C et al (2008) Diagnosis and treatment of bronchiectasis. Arch Bronconeumol 44:624–640CrossRefGoogle Scholar
  24. 24.
    Kosmas EN, Milic-Emili J, Retsou S et al (2009) Exercise testing and exercise limiting factors in patients with bilateral bronchiectasis. Pneumon 22:296–314Google Scholar
  25. 25.
    Guan WJ, Gao YH, Xu G et al (2015) Six-minute walk test in Chinese adults with clinically stable bronchiectasis: association with clinical indices and determinants. Curr Med Res Opin 31:843–852CrossRefPubMedGoogle Scholar
  26. 26.
    King PT, Holdsworth SR, Freezer NJ et al (2010) Lung diffusion capacity in adult bronchiectasis: a longitudinal study. Respir Care 55:1686–1692PubMedGoogle Scholar
  27. 27.
    Sheehan RE, Wells AU, Copley SJ et al (2002) A comparison of serial computed tomography and functional change in bronchiectasis. Eur Respir J 20:581–587CrossRefPubMedGoogle Scholar
  28. 28.
    Jurgensen SP, Antunes LC, Tanni SE et al (2011) The incremental shuttle walk test in older Brazilian adults. Respiration 81(3):223–228CrossRefPubMedGoogle Scholar
  29. 29.
    Ozalp O, Inal-Ince D, Calik E et al (2012) Extrapulmonary features of bronchiectasis: muscle function, exercise capacity, fatigue, and health status. Multidscip Respir Med 7:3CrossRefGoogle Scholar
  30. 30.
    Singer J, Yelin EH, Katz PP et al (2011) Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function. J Cardiopulm Rehabil Prev 31:111–119CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Martinez Garcia MA, Carro ML, Serra PC (2011) Treatment of non-cystic fibrosis bronchiestasis. Arch Bronconeumol 47:599–609PubMedGoogle Scholar
  32. 32.
    Mandal P, Sidhu MK, Donaldson LS et al (2013) Eight-weekly intravenous antibiotics is beneficial in severe bronchiectasis. QJM 106:27–33CrossRefPubMedGoogle Scholar
  33. 33.
    Aksamit TR, O’Donnell AE, Barker A et al (2017) Adults patients with bronchiectasis: a first look at the US bronchiectasis research registry. Chest 151:982–992CrossRefPubMedGoogle Scholar
  34. 34.
    Roberts HR, Wells AU, Milne DG et al (2000) Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 55:198–204CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Holland AE, Spruit MA, Troosters T et al (2014) An official European Respiratory Society/American Thoracic Society technical standard: field-walking tests in chronic respiratory disease. Eur Respir J 44:1428–1446CrossRefPubMedGoogle Scholar
  36. 36.
    Riberio LRG, Mesquita RB, Vidotto LS et al (2015) Are 30 minutes of rest between two incremental shuttle walking tests enough for cardiovascular variables and perceived exertion to return to baseline values? Braz J Phys Ther 19:105–113CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Physiotherapy and Rehabilitation, Faculty of Health SciencesHacettepe UniversityAnkaraTurkey
  2. 2.Department of Chest Medicine, Faculty of MedicineHacettepe UniversityAnkaraTurkey

Personalised recommendations